[go: up one dir, main page]

Maier et al., 2004 - Google Patents

Modulation of mammalian life span by the short isoform of p53

Maier et al., 2004

View PDF @Free from Publisher
Document ID
10715768010166663801
Author
Maier B
Gluba W
Bernier B
Turner T
Mohammad K
Guise T
Sutherland A
Thorner M
Scrable H
Publication year
Publication venue
Genes & development

External Links

Snippet

Overexpression of the short isoform of p53 (p44) has unexpectedly uncovered a role for p53 in the regulation of size and life span in the mouse. Hyperactivation of the insulin-like growth factor (IGF) signaling axis by p44 sets in motion a kinase cascade that clamps potentially …
Continue reading at genesdev.cshlp.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal

Similar Documents

Publication Publication Date Title
Maier et al. Modulation of mammalian life span by the short isoform of p53
Bagchi et al. HDAC11 suppresses the thermogenic program of adipose tissue via BRD2
Yan et al. Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish
Akiyama et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation
Sun et al. Mosaic mutant analysis identifies PDGFRα/PDGFRβ as negative regulators of adipogenesis
Ding et al. Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development
Lambert et al. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology
Jhala et al. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Vinciguerra et al. mIGF‐1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart
Kasher et al. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin‐induced hereditary spastic paraplegia (HSP) and human HSP patients
Kasper et al. Two transactivation mechanisms cooperate for the bulk of HIF‐1‐responsive gene expression
Cowley et al. The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development
Xing et al. Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1
Gomez-Villafuertes et al. Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons
Wu et al. MicroRNA‐574 regulates FAM210A expression and influences pathological cardiac remodeling
Huang et al. Transcription factor Hlx controls a systematic switch from white to brown fat through Prdm16-mediated co-activation
Kim et al. TRIM72 is required for effective repair of alveolar epithelial cell wounding
Lu et al. QKI regulates adipose tissue metabolism by acting as a brake on thermogenesis and promoting obesity
Gopinathan et al. The Wnt antagonist SFRP1: a key regulator of periodontal mineral homeostasis
Saifudeen et al. A role for p53 in terminal epithelial cell differentiation
Shi et al. Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour
Jiao et al. Mex3c regulates insulin-like growth factor 1 (IGF1) expression and promotes postnatal growth
Habtemichael et al. Insulin-stimulated endoproteolytic TUG cleavage links energy expenditure with glucose uptake
Al-Massadi et al. Pharmacological and genetic manipulation of p53 in brown fat at adult but not embryonic stages regulates thermogenesis and body weight in male mice
Shepherd et al. Mitochondrial proteome disruption in the diabetic heart through targeted epigenetic regulation at the mitochondrial heat shock protein 70 (mtHsp70) nuclear locus